Business
Golden Leaf Holdings Announces Appointment of Larry H. Martin to Board of Directors
Golden Leaf Holdings Announces Appointment of Larry H. Martin to Board of Directors.
About this update from Chalice Brands Ltd.
[{"type":"text","content":"\nPORTLAND, Ore., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced that Larry H. Martin has been appointed to the Company’s Board of Directors, effective today, filling a previously vacated board position. With his addition to the Board, he will join the Audit and Compensation Committees.\n Mr. Martin is a successful CEO and entrepreneur, with a unique background which includes over 39 years of domestic (i.e., United States) and international business experience in more than 11 different industries, including outdoor hospitality/living, branding, real estate and the medical industry. Mr. Martin also brings years of experience in FDA regulatory matters. Mr. Martin has served in various capacities, including CEO, Board Member, General Counsel and COO with the companies he has been involved with, including Field & Stream Licenses Company, LLC (which he founded), Eveia Medical, Inc., TNI Biotech, Inc., eMAX Health Systems LLC, US Summit Company, and Neuromed, Inc. Mr. Martin presently serves as a member of the board of advisors for Cupcake Digital, Inc. and on the board of CannaCore, Inc. Bill Kulczycki, CEO and President of Golden Leaf, stated “We are pleased to welcome Larry to Golden Leaf’s Board. We believe his background, experience and proven expertise as an entrepreneur, executive, and business affiliations across multiple industries, make him an ideal addition to our Board. We look forward to his contributions, as Golden Leaf looks to focus on disciplined growth, balanced between assessments of risk and cash flow returns that drive shareholder value creation, with the goal of achieving profitability in the near term.” Mr. Martin commented, “I am looking forward to working with Bill Kulczycki and the Golden Leaf board as the Company reassesses its strategies, refocuses its efforts on disciplined growth, and works to create shareholder value in this exciting industry. I believe that my experience and success in diverse industries, my background in branding and FDA regulatory matters, and my passion for helping companies grow profitably to create shareholder value, will benefit the Compa...